FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention relates to derivatives of taxane of the general formula (I):
wherein R2 means acyloxy-group; R7 means hydroxy-group; R9 means keto-group; R10 means carbonate; R14 means hydrogen atom; X3 means (C2-C6)-alkyl, (C2-C6)-alkenyl, (C3-C6)-cycloalkyl, phenyl substituted optionally with nitro-group or 5-6-membered heteroaromatic group comprising heteroatoms taken among oxygen (O), nitrogen (N) or sulfur (S) atoms; X5 means -C(O)X10, -C(O)OX10 or -CONHX10 wherein X10 means (C2-C6)-alkyl, (C2-C6)-alkenyl, (C3-C6)-cycloalkyl, phenyl, furyl, pyridyl or thienyl; Ac means acetyl. Also, invention describes a pharmaceutical composition based on taxanes and a method for inhibition of a tumor growth.
EFFECT: improved inhibiting method, valuable medicinal properties of compounds.
98 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
C7-ESTER-SUBSTITUTED TAXANES AS ANTI-TUMOR AGENTS | 2001 |
|
RU2265017C2 |
TAXANES, PHARMACEUTICAL COMPOSITIONS, INHIBITION METHOD | 2001 |
|
RU2265019C2 |
METHOD FOR SELECTIVE DERIVATIZATION OF TAXANES | 1998 |
|
RU2225402C2 |
IONIC TASK-1 AND TASK-3 CHANNEL INHIBITORS | 2007 |
|
RU2436577C2 |
METHODS AND COMPOSITIONS FOR GROWTH STIMULATION OF NEURITIS | 1996 |
|
RU2197240C2 |
METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE | 2001 |
|
RU2281094C2 |
APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) | 1994 |
|
RU2195282C2 |
METHOD FOR TREATING GLUTAMATE DISORDERS | 1997 |
|
RU2211697C2 |
PYRIDYLALKENE AND PYRIDYLALKYNE ACID AMIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF ITS PREPARING | 1997 |
|
RU2200734C2 |
CATALYST SYSTEM | 2003 |
|
RU2326123C2 |
Authors
Dates
2005-11-20—Published
2001-02-02—Filed